New drug targets Hard-to-Treat cancers in early trial
NCT ID NCT06597721
First seen Oct 31, 2025 · Last updated May 24, 2026 · Updated 28 times
Summary
This early-phase study tests an investigational drug called ADCE-T02 in people with advanced solid tumors that have not responded to prior treatments. The drug is designed to seek out and attack cancer cells by targeting a protein called tissue factor. The main goals are to find the safest dose and understand side effects, with around 210 participants expected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Cabrini Hospital
RECRUITINGMalvern, Victoria, 3144, Australia
-
Highlands Oncology Group
RECRUITINGRogers, Arkansas, 72758, United States
-
Linear Clinical Research
RECRUITINGNedlands, Western Australia, 6009, Australia
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
Macquarie University Hospital
RECRUITINGMacquarie Park, New South Wales, 2109, Australia
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
-
Peninsula and South Eastern Haematology and Oncology Group (PSEHOG)
RECRUITINGFrankston, Victoria, 3199, Australia
-
START San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
-
Scientia Clinical Research
RECRUITINGRandwick, New South Wales, 2031, Australia
-
Southern Oncology Clinical Research Unit
RECRUITINGBedford Park, South Australia, 5042, Australia
-
Yale University Cancer Center
RECRUITINGNew Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.